You’re using a public version of DrugChatter with 10 free searches available. Register to unlock more free searches per day. CREATE FREE ACCOUNT

Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.


What are the common gastrointestinal side effects of darolutamide?

See the DrugPatentWatch profile for darolutamide

Darolutamide is a medication used in the treatment of prostate cancer. It is important to be aware of the potential side effects associated with this drug, particularly those related to the gastrointestinal system. The sources you provided offer valuable information on this topic.

According to the Drug Patent Watch website, the common gastrointestinal side effects of darolutamide include nausea, diarrhea, and decreased appetite [1]. These side effects are also mentioned on the website, which further adds that abdominal pain and vomiting may occur as well [2].

A study published in the National Center for Biotechnology Information (NCBI) also highlights gastrointestinal side effects associated with darolutamide. The study reports that diarrhea is the most common adverse event related to this medication, occurring in approximately 13% of patients [3].

It is important to note that while these sources provide information on common gastrointestinal side effects of darolutamide, individual experiences may vary. It is recommended to consult with a healthcare professional for personalized advice and guidance regarding potential side effects and management strategies.

In summary, the common gastrointestinal side effects of darolutamide include nausea, diarrhea, decreased appetite, abdominal pain, and vomiting. These side effects may occur in a subset of patients and it is advisable to consult a healthcare professional for personalized advice.

[1] Drug Patent Watch. (n.d.). Darolutamide. Retrieved from
[2] (n.d.). Darolutamide Side Effects. Retrieved from
[3] Tran, C., Oudard, S., Roca, E., Loriot, Y., & Fizazi, K. (2020). Current developments of darolutamide in prostate cancer: an up-to-date review of its safety, efficacy, and clinical potential. Therapeutic Advances in Medical Oncology, 12, 1-14. doi: 10.1177/1758835920902485

Other Questions About Darolutamide :  What are the possible side effects of darolutamide? Is darolutamide associated with hair loss? What measures can be taken to manage darolutamide related gastrointestinal issues?

DrugPatentWatch - Make Better Decisions
© thinkBiotech LLC 2004 - 2024. All rights reserved. Privacy